How targeting subclinical populations with a rapid saliva test may aid in the quest to eradicate the disease.
Marcus Horwitz’s primary focus is on infectious diseases, but a number of pathogens he has studied led him into the realm of bio-terrorism.
A screen of 2000 synthetic compounds has uncovered a novel agent against antiviral resistant influenza.
A antibody discovery platform emerges to tackle the growing problem of Andes Hantavirus cardiopulmonary syndrome (AHCPS)
A vaccine using mRNA demonstrates potential for broad influenza protection.
Bill Gates has issued a challenge to help researchers push for a universal flu vaccine.
Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?
Sitting Down With… Carolyn Bertozzi, Anne T. and Robert M. Bass Professor of Chemistry, and Professor (by courtesy) of Chemical & Systems Biology and Radiology,Stanford University, USA.
Can an oral fluid assay for HIV be as sensitive as a blood test?
Should we target minor rather than major infections with new therapeutics to best fight antibiotic resistance?
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.